Association of blood pressure, its treatment, and treatment efficacy with volume of white matter hyperintensities in the population-based 1000BRAINS Study
Hypertension Oct 16, 2021
Gronewold J, Jokisch M, Schramm S, et al. - In this study, white matter hyperintensities (WMHs) are identified as a marker of advanced hypertension pathology, and therefore, early treatment should avert WMHs.
WMHs of presumed vascular origin are implicated in the pathogenesis of cognitive decline.
A total of 560 participants of the 1000BRAINS study, selected from the population-based Heinz Nixdorf Recall study (65.2±7.5 years; 51.4% men), were analyzed to examine the link of systolic blood pressure (SBP), diastolic blood pressure (DBP), and antihypertensive medications with WMH volume.
Multivariable linear regression models showed significant link with WMH volume of the following: continuous SBP (β=0.63 cm 3 per 10 mm Hg), DBP (0.64 cm 3 per 5 mmHg), and antihypertensive treatment (1.23 cm 3 ).
With respect to treatment efficacy, significantly increased WMH volume (4.24 cm 3 [2.36–6.13]) was detected in only participants with hypertension despite treatment (treated BP ≥140 or ≥90 mm Hg) vs normotensive without treatment (untreated BP <120/<80 mm Hg).
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries